Cardiology

Demonstrate the application of Doppler principles to assessing hemodynamics including valvular heart disease, Demonstrate use of echocardiography to assess prosthetic valves, Demonstrate and interpret diastolic echocardiographic measurements, Apply echocardiographic principles in the assessment of heart failure

Participants are provided with an integrated platform to acquire new skills and abilities that will improve aptitude in caring for CRRT patients; increase working knowledge of the CRRT machine and ability to troubleshoot alarms; enhance abilities to navigate and adapt to complex situations involving CRRT; develop strategies for addressing challenging communication issues and program structure. Limit 12 participants per session.

Describe the normal electrical conduction pathway through the heart, Identify ECG waveforms, Interpret cardiac rhythms, and Identify basic interventions.

The event aims to provide a clear understanding of the current state of the field across different countries and to encourage collaboration and progress in the field. The event will also provide opportunities for academic research, with the publication of original research papers, review papers, surveys, case studies, technical and management reports,

The course will also review cardiovascular risk in patients with thyroid disorders, including heart failure with Graves disease, myxedema and thyroid hormone replacement.A special research presentation on lipid droplet biology will highlight important ongoing research in lipid metabolism. The course will provide updates on the role of inflammation, hypertriglyceridemia, and lipoprotein(a) in cardiovascular disease risk.

A special research presentation on lipid droplet biology will highlight important ongoing research in lipid metabolism. The course will provide updates on the role of inflammation, hypertriglyceridemia, and lipoprotein(a) in cardiovascular disease risk. There will be an hour-long case conference with challenging cases in cardiovascular disease risk reduction. The course includes morning and afternoon panel discussion segments including an audience question-and-answer time

This symposium is designed to provide a dedicated forum to discuss the diagnosis and management of patients with coronary artery anomalies (CAA). Topics will include anomalous aortic origin of a coronary artery (AAOCA) and myocardial bridges.

Our goal is to bring together key players in these fields to work collaboratively and find solutions to these pressing challenges. Throughout the conference, we will focus on recognizing current and future obstacles and finding ways to overcome them through insightful discussions and knowledge-sharing sessions. Attendees will have the chance to exchange information and ideas derived from international research and studies, as well as build valuable professional connections.

The main themes in 2024 will be valvular heart disease and precision medicine. Join world-renowned experts in all modalities of cardiovascular imaging. It is also a fantastic opportunity to expand your network, to exchange ideas and build projects with colleagues.

The course emphasizes the importance of CPR to patient survival, the integration of effective basic life support with advanced cardiovascular life support interventions, and the importance of effective team interaction and communication during resuscitation.

Discuss new information about the treatment of lower extremity venous disease, Demonstrate treatment options for visceral and renal artery aneurysm and occlusive disease, Evaluate new developments in the management of complex venous disease, Recall information on the latest in treatment of upper extremity vascular disease

Lectures will be given by internationally recognized experts who will address the newest clinical trials published in the field, and review standard and emerging treatments for patients with cardiovascular diseases. Didactic sessions, case presentations and interactive discussions will engender learning and improvement in the management of patients with the full spectrum of cardiovascular disease.